NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers Post Job | Search Resumes

NEWSLETTERS
Free Newsletters
Archive

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News

CAREER NETWORK
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

DIVERSITY

HOTBEDS
Regional News
Biotech Bay™
Biotech Beach™
Genetown™
Pharm Country™
BioCapital™
BioMidwest™
Bio NC™
BioForest™
Southern Pharm™
BioCanada East™
US Device™

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
BioPharm Insight

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities


Friday, May 09, 2008
 
Osiris Therapeutics, Inc. (OSIR) and NuVasive, Inc. (NUVA) Enter into Definitive Agreement for Osteocel(R) for Up to $85 Million in Upfront and Milestone Payments    More...

FDA Delays Decision on Adolor Corporation (ADLR), GlaxoSmithKline (GSK) Bowel Drug    More...

Enzo Biochem (ENZ) Acquires BIOMOL International, Further Expanding Its Life Sciences Operations    More...

Spectrum Pharmaceuticals, Inc. (SPPI) Announces Sale of Injectable Generic Drugs to Sagent Pharmaceuticals, Inc.    More...

Applera Corporation (ABI)s Board of Directors Formally Approves Proposed Separation of Its Celera Business    More...

Otsuka Pharmaceutical Co., Ltd., Bristol-Myers Squibb Company (BMY) ABILIFY(R) Receives Expanded Indications for Maintenance Treatment in Both Pediatric Patients (Aged 10-17) With Manic and Mixed Episodes of Bipolar I Disorder and Adolescents (Aged 13-17) With Schizophrenia    More...

FDA Grants Priority Review of Talecris Biotherapeutics's Gamunex(R) as a Treatment for Neurological Disorder CIDP    More...

Bristol-Myers Squibb Company (BMY) CEO Buys 100,000 Shares    More...

 
More Breaking News

 Market Summary

 Yesterday's Most Popular News 
May 8, 2008

Dos and Don'ts for Second (and Subsequent) Job Interviews More...
Biovail Corporation (BVF) Announces New Strategic Focus; Close Plants and Take Charges More...
Is There an Elephant in the Room? More...
What To Do When You Are Overqualified More...
Why Should We Hire You? More...
Novartis Corporation (NVS) Buys More Alnylam Pharmaceuticals (ALNY) Stock for $5.4 Million More...
FDA Sets Panel Review of GlaxoSmithKline (GSK) Clotting Drug According to Amgen (AMGN) More...
Array BioPharma, Inc. (ARRY) Presents Additional Positive Phase 2 Results in Inflammatory Pain Clinical Trial; ARRY-797 Achieved its Primary and Secondary Endpoints More...
Osiris Therapeutics, Inc. (OSIR) Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program More...
FDA Approves Eli Lilly and Company (LLY)'s Strattera(R) for Maintenance of ADHD in Children and Adolescents More...